Impaired endothelial function in persons with obstructive sleep apnoea

Impact of obesity

Silje K. Namtvedt, Jonny Hisdal, Anna Randby, Stefan Agewall, Einar Stranden, Virend Somers, Helge Røsjø, Torbjørn Omland

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Objective: Obstructive sleep apnoea (OSA) and obesity are both associated with endothelial dysfunction, which precedes the development of atherosclerosis. As obesity is highly prevalent in OSA, we wanted to test the hypothesis that OSA is associated with endothelial dysfunction independently of obesity. Design: Cross-sectional, population-based study. Setting: Norwegian university hospital. Patients: Seventy-one subjects (median age 44 years, 35% female) were recruited from a population-based study in Norway. Participants were categorised as obese (body mass index (BMI) ≥30 kg/m2), non-obese (BMI<30 kg/m2) with OSA (apnoea - hypopnoea index (AHI)≥10), or non-obese without OSA (AHI<5). Interventions: None. Main outcome measures: Endothelial function measured by brachial artery ultrasound and expressed as percentage of flow-mediated dilation (FMD%). Results: When non-obese subjects without OSA were used as the reference (FMD% (mean±SD) 10.1±6.3), endothelial function was found to be impaired in subjects with OSA (FMD% 6.4±3.2) (p=0.003). FMD% did not differ between obese (6.0±3.4) and non-obese (6.7±3.1) OSA subjects ( p=0.3). By univariate linear regression analysis, AHI, BMI, gender and baseline brachial artery diameter were significantly associated with FMD%. When these variables were entered into a multivariate model, only AHI was signi ficantly associated with FMD%. Conclusions: OSA is associated with endothelial dysfunction independently of obesity and conventional risk factors.

Original languageEnglish (US)
Pages (from-to)30-34
Number of pages5
JournalHeart
Volume99
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Obstructive Sleep Apnea
Obesity
Dilatation
Apnea
Body Mass Index
Brachial Artery
Norway
Population
Linear Models
Atherosclerosis
Regression Analysis
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Namtvedt, S. K., Hisdal, J., Randby, A., Agewall, S., Stranden, E., Somers, V., ... Omland, T. (2013). Impaired endothelial function in persons with obstructive sleep apnoea: Impact of obesity. Heart, 99(1), 30-34. https://doi.org/10.1136/heartjnl-2012-303009

Impaired endothelial function in persons with obstructive sleep apnoea : Impact of obesity. / Namtvedt, Silje K.; Hisdal, Jonny; Randby, Anna; Agewall, Stefan; Stranden, Einar; Somers, Virend; Røsjø, Helge; Omland, Torbjørn.

In: Heart, Vol. 99, No. 1, 01.2013, p. 30-34.

Research output: Contribution to journalArticle

Namtvedt, SK, Hisdal, J, Randby, A, Agewall, S, Stranden, E, Somers, V, Røsjø, H & Omland, T 2013, 'Impaired endothelial function in persons with obstructive sleep apnoea: Impact of obesity', Heart, vol. 99, no. 1, pp. 30-34. https://doi.org/10.1136/heartjnl-2012-303009
Namtvedt, Silje K. ; Hisdal, Jonny ; Randby, Anna ; Agewall, Stefan ; Stranden, Einar ; Somers, Virend ; Røsjø, Helge ; Omland, Torbjørn. / Impaired endothelial function in persons with obstructive sleep apnoea : Impact of obesity. In: Heart. 2013 ; Vol. 99, No. 1. pp. 30-34.
@article{365874ae24574843acfd44d2ced43034,
title = "Impaired endothelial function in persons with obstructive sleep apnoea: Impact of obesity",
abstract = "Objective: Obstructive sleep apnoea (OSA) and obesity are both associated with endothelial dysfunction, which precedes the development of atherosclerosis. As obesity is highly prevalent in OSA, we wanted to test the hypothesis that OSA is associated with endothelial dysfunction independently of obesity. Design: Cross-sectional, population-based study. Setting: Norwegian university hospital. Patients: Seventy-one subjects (median age 44 years, 35{\%} female) were recruited from a population-based study in Norway. Participants were categorised as obese (body mass index (BMI) ≥30 kg/m2), non-obese (BMI<30 kg/m2) with OSA (apnoea - hypopnoea index (AHI)≥10), or non-obese without OSA (AHI<5). Interventions: None. Main outcome measures: Endothelial function measured by brachial artery ultrasound and expressed as percentage of flow-mediated dilation (FMD{\%}). Results: When non-obese subjects without OSA were used as the reference (FMD{\%} (mean±SD) 10.1±6.3), endothelial function was found to be impaired in subjects with OSA (FMD{\%} 6.4±3.2) (p=0.003). FMD{\%} did not differ between obese (6.0±3.4) and non-obese (6.7±3.1) OSA subjects ( p=0.3). By univariate linear regression analysis, AHI, BMI, gender and baseline brachial artery diameter were significantly associated with FMD{\%}. When these variables were entered into a multivariate model, only AHI was signi ficantly associated with FMD{\%}. Conclusions: OSA is associated with endothelial dysfunction independently of obesity and conventional risk factors.",
author = "Namtvedt, {Silje K.} and Jonny Hisdal and Anna Randby and Stefan Agewall and Einar Stranden and Virend Somers and Helge R{\o}sj{\o} and Torbj{\o}rn Omland",
year = "2013",
month = "1",
doi = "10.1136/heartjnl-2012-303009",
language = "English (US)",
volume = "99",
pages = "30--34",
journal = "Heart",
issn = "1355-6037",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - Impaired endothelial function in persons with obstructive sleep apnoea

T2 - Impact of obesity

AU - Namtvedt, Silje K.

AU - Hisdal, Jonny

AU - Randby, Anna

AU - Agewall, Stefan

AU - Stranden, Einar

AU - Somers, Virend

AU - Røsjø, Helge

AU - Omland, Torbjørn

PY - 2013/1

Y1 - 2013/1

N2 - Objective: Obstructive sleep apnoea (OSA) and obesity are both associated with endothelial dysfunction, which precedes the development of atherosclerosis. As obesity is highly prevalent in OSA, we wanted to test the hypothesis that OSA is associated with endothelial dysfunction independently of obesity. Design: Cross-sectional, population-based study. Setting: Norwegian university hospital. Patients: Seventy-one subjects (median age 44 years, 35% female) were recruited from a population-based study in Norway. Participants were categorised as obese (body mass index (BMI) ≥30 kg/m2), non-obese (BMI<30 kg/m2) with OSA (apnoea - hypopnoea index (AHI)≥10), or non-obese without OSA (AHI<5). Interventions: None. Main outcome measures: Endothelial function measured by brachial artery ultrasound and expressed as percentage of flow-mediated dilation (FMD%). Results: When non-obese subjects without OSA were used as the reference (FMD% (mean±SD) 10.1±6.3), endothelial function was found to be impaired in subjects with OSA (FMD% 6.4±3.2) (p=0.003). FMD% did not differ between obese (6.0±3.4) and non-obese (6.7±3.1) OSA subjects ( p=0.3). By univariate linear regression analysis, AHI, BMI, gender and baseline brachial artery diameter were significantly associated with FMD%. When these variables were entered into a multivariate model, only AHI was signi ficantly associated with FMD%. Conclusions: OSA is associated with endothelial dysfunction independently of obesity and conventional risk factors.

AB - Objective: Obstructive sleep apnoea (OSA) and obesity are both associated with endothelial dysfunction, which precedes the development of atherosclerosis. As obesity is highly prevalent in OSA, we wanted to test the hypothesis that OSA is associated with endothelial dysfunction independently of obesity. Design: Cross-sectional, population-based study. Setting: Norwegian university hospital. Patients: Seventy-one subjects (median age 44 years, 35% female) were recruited from a population-based study in Norway. Participants were categorised as obese (body mass index (BMI) ≥30 kg/m2), non-obese (BMI<30 kg/m2) with OSA (apnoea - hypopnoea index (AHI)≥10), or non-obese without OSA (AHI<5). Interventions: None. Main outcome measures: Endothelial function measured by brachial artery ultrasound and expressed as percentage of flow-mediated dilation (FMD%). Results: When non-obese subjects without OSA were used as the reference (FMD% (mean±SD) 10.1±6.3), endothelial function was found to be impaired in subjects with OSA (FMD% 6.4±3.2) (p=0.003). FMD% did not differ between obese (6.0±3.4) and non-obese (6.7±3.1) OSA subjects ( p=0.3). By univariate linear regression analysis, AHI, BMI, gender and baseline brachial artery diameter were significantly associated with FMD%. When these variables were entered into a multivariate model, only AHI was signi ficantly associated with FMD%. Conclusions: OSA is associated with endothelial dysfunction independently of obesity and conventional risk factors.

UR - http://www.scopus.com/inward/record.url?scp=84871304454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871304454&partnerID=8YFLogxK

U2 - 10.1136/heartjnl-2012-303009

DO - 10.1136/heartjnl-2012-303009

M3 - Article

VL - 99

SP - 30

EP - 34

JO - Heart

JF - Heart

SN - 1355-6037

IS - 1

ER -